Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | |
| Sales | 55 | 292 | 0 |
| Cost of Goods | 638 | 805 | N/A |
| Gross Profit | -583 | -513 | N/A |
| Operating Expenses | 5,233 | 4,640 | 0 |
| Operating Income | -5,178 | -4,348 | N/A |
| Interest Expense | 618 | 1,019 | 0 |
| Other Income | 208 | 202 | 0 |
| Pre-tax Income | -5,588 | -5,165 | 0 |
| Net Income Continuous | -5,588 | -5,165 | N/A |
| Net Income | $-5,588 | $-5,165 | $N/A |
| EPS Basic Total Ops | -7.33 | -6.91 | N/A |
| EPS Basic Continuous Ops | -6.40 | -6.91 | N/A |
| EPS Diluted Total Ops | -7.33 | -6.91 | N/A |
| EPS Diluted Continuous Ops | -6.40 | -6.91 | N/A |
| EBITDA(a) | $-4,501 | $-3,371 | $N/A |